IBDEI0LB ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10100,0)
 ;;=227.3^^44^561^103
 ;;^UTILITY(U,$J,358.3,10100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10100,1,3,0)
 ;;=3^Pituitary/Craniopharyngeal Neopl,Benign
 ;;^UTILITY(U,$J,358.3,10100,1,4,0)
 ;;=4^227.3
 ;;^UTILITY(U,$J,358.3,10100,2)
 ;;=^267690
 ;;^UTILITY(U,$J,358.3,10101,0)
 ;;=237.0^^44^561^104
 ;;^UTILITY(U,$J,358.3,10101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10101,1,3,0)
 ;;=3^Pituitary/Craniopharyngeal Neopl,Uncert
 ;;^UTILITY(U,$J,358.3,10101,1,4,0)
 ;;=4^237.0
 ;;^UTILITY(U,$J,358.3,10101,2)
 ;;=^81969
 ;;^UTILITY(U,$J,358.3,10102,0)
 ;;=250.52^^44^561^27
 ;;^UTILITY(U,$J,358.3,10102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10102,1,3,0)
 ;;=3^DM II w/Ophthalmic,Uncontrolled
 ;;^UTILITY(U,$J,358.3,10102,1,4,0)
 ;;=4^250.52
 ;;^UTILITY(U,$J,358.3,10102,2)
 ;;=^331801
 ;;^UTILITY(U,$J,358.3,10103,0)
 ;;=253.8^^44^561^35
 ;;^UTILITY(U,$J,358.3,10103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10103,1,3,0)
 ;;=3^Empty Sella/Turcica
 ;;^UTILITY(U,$J,358.3,10103,1,4,0)
 ;;=4^253.8
 ;;^UTILITY(U,$J,358.3,10103,2)
 ;;=^87533
 ;;^UTILITY(U,$J,358.3,10104,0)
 ;;=300.11^^44^561^55
 ;;^UTILITY(U,$J,358.3,10104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10104,1,3,0)
 ;;=3^Hysterical Blindness
 ;;^UTILITY(U,$J,358.3,10104,1,4,0)
 ;;=4^300.11
 ;;^UTILITY(U,$J,358.3,10104,2)
 ;;=^28139
 ;;^UTILITY(U,$J,358.3,10105,0)
 ;;=307.81^^44^561^48
 ;;^UTILITY(U,$J,358.3,10105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10105,1,3,0)
 ;;=3^Headache,Tension
 ;;^UTILITY(U,$J,358.3,10105,1,4,0)
 ;;=4^307.81
 ;;^UTILITY(U,$J,358.3,10105,2)
 ;;=^100405
 ;;^UTILITY(U,$J,358.3,10106,0)
 ;;=325.^^44^561^18
 ;;^UTILITY(U,$J,358.3,10106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10106,1,3,0)
 ;;=3^Cavernous Sinus Thrombosis
 ;;^UTILITY(U,$J,358.3,10106,1,4,0)
 ;;=4^325.
 ;;^UTILITY(U,$J,358.3,10106,2)
 ;;=^268392
 ;;^UTILITY(U,$J,358.3,10107,0)
 ;;=332.0^^44^561^100
 ;;^UTILITY(U,$J,358.3,10107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10107,1,3,0)
 ;;=3^Parkinson's
 ;;^UTILITY(U,$J,358.3,10107,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,10107,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,10108,0)
 ;;=334.3^^44^561^19
 ;;^UTILITY(U,$J,358.3,10108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10108,1,3,0)
 ;;=3^Cerebella Ataxia
 ;;^UTILITY(U,$J,358.3,10108,1,4,0)
 ;;=4^334.3
 ;;^UTILITY(U,$J,358.3,10108,2)
 ;;=^87376
 ;;^UTILITY(U,$J,358.3,10109,0)
 ;;=337.9^^44^561^52
 ;;^UTILITY(U,$J,358.3,10109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10109,1,3,0)
 ;;=3^Horner's Syndrome
 ;;^UTILITY(U,$J,358.3,10109,1,4,0)
 ;;=4^337.9
 ;;^UTILITY(U,$J,358.3,10109,2)
 ;;=^11827
 ;;^UTILITY(U,$J,358.3,10110,0)
 ;;=341.9^^44^561^28
 ;;^UTILITY(U,$J,358.3,10110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10110,1,3,0)
 ;;=3^Demyelinating Disease
 ;;^UTILITY(U,$J,358.3,10110,1,4,0)
 ;;=4^341.9
 ;;^UTILITY(U,$J,358.3,10110,2)
 ;;=^31807
 ;;^UTILITY(U,$J,358.3,10111,0)
 ;;=346.00^^44^561^63
 ;;^UTILITY(U,$J,358.3,10111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10111,1,3,0)
 ;;=3^Migraine,Classic,Not Intractable
 ;;^UTILITY(U,$J,358.3,10111,1,4,0)
 ;;=4^346.00
 ;;^UTILITY(U,$J,358.3,10111,2)
 ;;=^336875
 ;;^UTILITY(U,$J,358.3,10112,0)
 ;;=346.01^^44^561^62
 ;;^UTILITY(U,$J,358.3,10112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10112,1,3,0)
 ;;=3^Migraine,Classic,Intractable
 ;;^UTILITY(U,$J,358.3,10112,1,4,0)
 ;;=4^346.01
 ;;^UTILITY(U,$J,358.3,10112,2)
 ;;=^336828
 ;;^UTILITY(U,$J,358.3,10113,0)
 ;;=346.10^^44^561^61
 ;;^UTILITY(U,$J,358.3,10113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10113,1,3,0)
 ;;=3^Migraine w/o Aura,Not Intractable
 ;;
 ;;$END ROU IBDEI0LB
